Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring and Overcoming Challenges for Efficient Audiological Testing in Children Under 5 Years of Age-Screening with Otoacoustic Emissions.

Audiology research·2026
Same author

A subset of image-defined risk factors predict completeness of resection in children with high-risk neuroblastoma: An international multicenter study.

Pediatric blood & cancer·2024
Same author

Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.

Pediatric blood & cancer·2023

Related Experiment Video

Updated: Oct 21, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.6K

New insights into cisplatin ototoxicity.

Penelope R Brock1

  • 1Oncology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.

Cancer
|September 7, 2021
PubMed
Summary

Platinum chemotherapy, vital for childhood cancer, risks permanent hearing loss. Early, frequent hearing tests are crucial for younger children undergoing this treatment.

Area of Science:

  • Pediatric Oncology
  • Ototoxicity Research
  • Cancer Therapeutics

Background:

  • Platinum-based chemotherapy is a cornerstone in treating pediatric cancers.
  • A significant side effect is permanent hearing loss in over 50% of young patients.
  • Early identification of hearing loss risk is critical for intervention.

Discussion:

  • Meijer and colleagues' research highlights early-onset hearing impairment in young children receiving platinum chemotherapy.
  • The study proposes increased hearing surveillance for younger children during treatment.
  • Implementing this recommendation presents practical, emotional, and socioeconomic challenges for healthcare centers and families.

Key Insights:

  • Younger children are particularly vulnerable to platinum-induced hearing loss early in their treatment.
Keywords:
cisplatinototoxicityototoxicity gradingvincristineyoung child

More Related Videos

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

6.0K
Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection
11:13

Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection

Published on: March 28, 2012

24.1K

Related Experiment Videos

Last Updated: Oct 21, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

9.6K
Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

6.0K
Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection
11:13

Dissection of Adult Mouse Utricle and Adenovirus-mediated Supporting-cell Infection

Published on: March 28, 2012

24.1K
  • A proactive approach with more frequent audiological monitoring is suggested for this demographic.
  • The findings underscore the need for a multidisciplinary care approach.

    • Outlook:

    • This research may pave the way for revised clinical guidelines in pediatric cancer care.
    • It encourages a shift towards integrated audiological monitoring within oncology treatment plans.
    • Future efforts should focus on developing strategies to mitigate chemotherapy-induced ototoxicity and support affected children.